580 related articles for article (PubMed ID: 11704856)
1. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
2. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
Engelhardt OG; Ullrich E; Kochs G; Haller O
Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
[TBL] [Abstract][Full Text] [Related]
3. Induction of the PML protein by interferons in normal and APL cells.
Chelbi-Alix MK; Pelicano L; Quignon F; Koken MH; Venturini L; Stadler M; Pavlovic J; Degos L; de Thé H
Leukemia; 1995 Dec; 9(12):2027-33. PubMed ID: 8609713
[TBL] [Abstract][Full Text] [Related]
4. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins.
Chelbi-Alix MK; de Thé H
Oncogene; 1999 Jan; 18(4):935-41. PubMed ID: 10023669
[TBL] [Abstract][Full Text] [Related]
5. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.
Regad T; Saib A; Lallemand-Breitenbach V; Pandolfi PP; de Thé H; Chelbi-Alix MK
EMBO J; 2001 Jul; 20(13):3495-505. PubMed ID: 11432836
[TBL] [Abstract][Full Text] [Related]
6. Viruses as hijackers of PML nuclear bodies.
Möller A; Schmitz ML
Arch Immunol Ther Exp (Warsz); 2003; 51(5):295-300. PubMed ID: 14626429
[TBL] [Abstract][Full Text] [Related]
7. SUMO: of branched proteins and nuclear bodies.
Seeler JS; Dejean A
Oncogene; 2001 Oct; 20(49):7243-9. PubMed ID: 11704852
[TBL] [Abstract][Full Text] [Related]
8. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
[TBL] [Abstract][Full Text] [Related]
9. The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies.
Ruthardt M; Orleth A; Tomassoni L; Puccetti E; Riganelli D; Alcalay M; Mannucci R; Nicoletti I; Grignani F; Fagioli M; Pelicci PG
Oncogene; 1998 Apr; 16(15):1945-53. PubMed ID: 9591778
[TBL] [Abstract][Full Text] [Related]
10. The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
Lavau C; Marchio A; Fagioli M; Jansen J; Falini B; Lebon P; Grosveld F; Pandolfi PP; Pelicci PG; Dejean A
Oncogene; 1995 Sep; 11(5):871-6. PubMed ID: 7545807
[TBL] [Abstract][Full Text] [Related]
11. PML and PML nuclear bodies: implications in antiviral defence.
Everett RD; Chelbi-Alix MK
Biochimie; 2007; 89(6-7):819-30. PubMed ID: 17343971
[TBL] [Abstract][Full Text] [Related]
12. Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies.
Chelbi-Alix MK; Vidy A; El Bougrini J; Blondel D
J Interferon Cytokine Res; 2006 May; 26(5):271-80. PubMed ID: 16689655
[TBL] [Abstract][Full Text] [Related]
13. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies.
Fuchsová B; Novák P; Kafková J; Hozák P
J Cell Biol; 2002 Aug; 158(3):463-73. PubMed ID: 12163469
[TBL] [Abstract][Full Text] [Related]
14. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.
Pampin M; Simonin Y; Blondel B; Percherancier Y; Chelbi-Alix MK
J Virol; 2006 Sep; 80(17):8582-92. PubMed ID: 16912307
[TBL] [Abstract][Full Text] [Related]
15. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
[TBL] [Abstract][Full Text] [Related]
16. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
Adamson AL; Kenney S
J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
[TBL] [Abstract][Full Text] [Related]
17. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
18. Role of promyelocytic leukemia protein in host antiviral defense.
Geoffroy MC; Chelbi-Alix MK
J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
[TBL] [Abstract][Full Text] [Related]
19. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies.
Blondel D; Regad T; Poisson N; Pavie B; Harper F; Pandolfi PP; De Thé H; Chelbi-Alix MK
Oncogene; 2002 Nov; 21(52):7957-70. PubMed ID: 12439746
[TBL] [Abstract][Full Text] [Related]
20. PML-nuclear bodies accumulate DNA in response to polyomavirus BK and simian virus 40 replication.
Jul-Larsen A; Visted T; Karlsen BO; Rinaldo CH; Bjerkvig R; Lønning PE; Bøe SO
Exp Cell Res; 2004 Aug; 298(1):58-73. PubMed ID: 15242762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
